Neuropsychiatric outcomes before and after switching to dolutegravir-based therapy in an acute HIV cohort
information for practice - open access journal articles,
Dolutegravir (DTG)-based antiretroviral therapy (ART) is currently the first-line treatment for people living with HIV.